Evenamide
CAS No. 1092977-61-1
Evenamide( NW-3509 )
Catalog No. M23295 CAS No. 1092977-61-1
Evenamide is a sodium channel blocker.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 222 | In Stock |
|
10MG | 357 | In Stock |
|
25MG | 597 | In Stock |
|
50MG | 851 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEvenamide
-
NoteResearch use only, not for human use.
-
Brief DescriptionEvenamide is a sodium channel blocker.
-
DescriptionEvenamide is a sodium channel blocker. Which shows efficacy in a broad spectrum of rodent models of psychosis, mania, depression, and aggressiveness.
-
In VitroEvenamide selectively blocks voltage-gated sodium channels (VGSCs) in a voltage-and use-dependent manner (Ki=0.4 μM) and modulates sustained repetitive firing without inducing impairment of the normal neuronal excitability. Evenamide does not bind, inhibit or interact with over 130 receptors, enzymes, or transporters.
-
In VivoEvenamide is active in a wide range of psychiatric animal models in monotherapy and addon to antipsychotics. Evenamide is effective in attenuating the social interaction deficit in Cl 395 (PCP)-impaired rats (MED=1 mg/kg po).
-
SynonymsNW-3509
-
PathwayMembrane Transporter/Ion Channel
-
TargetSodium Channel
-
RecptorSodium channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1092977-61-1
-
Formula Weight278.39
-
Molecular FormulaC16H26N2O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:290 mg/mL (1041.70 mM; Need ultrasonic)
-
SMILESCCCCOc1cccc(CCNCC(N(C)C)=O)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Valentina Zuliani, et al. Advances in Design and Development of Sodium Channel Blockers. Ion Channels and Their Inhibitors pp 79-115.
molnova catalog
related products
-
BI 01383298
BI 01383298 is a selective inhibitor of the sodium-citrate co-transporter (SLC13A5).
-
PF-06869206
PF-06869206 is an oral selective inhibitor of the sodium-phosphate cotransporter NaPi2a (SLC34A1, IC50: 380 nM).
-
N-Me-aminopyrimidino...
N-Me-aminopyrimidinone9 is a sodium channel antagonist.